TABLE 7.
Seroreactivity in a non-U.S. endemic populationa
| Test kit | No. of samples |
% reactive | 95% CI | P | ||
|---|---|---|---|---|---|---|
| Pos | Equ | Neg | ||||
| BioPlex 2200 Lyme Total | 9 | 1 | 90 | 10.0 | 5.5–17.4 | Ref |
| Immunetics Lyme C6 | 7 | 0 | 93 | 7.0 | 3.4–13.8 | 0.581 |
| Zeus Borrelia VlsE1/pepC10 | 2 | 5 | 93 | 7.0 | 3.4–13.8 | 0.629 |
| DiaSorin LIAISON Borrelia (lgM+IgG) | 29 | 8 | 63 | 37.0 | 28.2–46.8 | <0.001 |
| DiaSorin LIAISON Borrelia IgM II | 26 | 2 | 72 | 28.0 | 20.1–37.5 | 0.003 |
| DiaSorin LIAISON Borrelia IgG | 3 | 6 | 91 | 9.0 | 4.8–16.2 | 1.000 |
a
Asymptomatic donor samples (n = 100) collected from an area of endemicity within Russia were assessed for reactivity to the following commercially available Lyme test kits. 95% CI, 95% confidence interval; Ref, reference.